Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone

Fig. 3

Staining wound healing and Boyden chamber assays with a double cytochemical labeling allowed for the observation of varying migration patterns along disease progression. Cells were labelled with Alexa Fluor-594 Phalloidin, to stain for the cytoskeleton, and either DAPI (A[i, ii], B[i, ii]) or SYTOX green (A[iii, iv], B[iii, iv]), to stain for the nucleus. Scale bar = 100 µm. White dashed lines represent the front of the wound

Back to article page